Scinai Immunotherapeutics Ltd. American Depositary Shares

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SCNI and other ETFs, options, and stocks.

About SCNI

Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. 

CEO
Amir Reichman
CEOAmir Reichman
Employees
31
Employees31
Headquarters
Jerusalem, Jerusalem
HeadquartersJerusalem, Jerusalem
Founded
2003
Founded2003
Employees
31
Employees31

SCNI Key Statistics

Market cap
2.10M
Market cap2.10M
Price-Earnings ratio
0.43
Price-Earnings ratio0.43
Dividend yield
—
Dividend yield—
Average volume
40.37K
Average volume40.37K
High today
$2.65
High today$2.65
Low today
$2.35
Low today$2.35
Open price
$2.60
Open price$2.60
Volume
36.60K
Volume36.60K
52 Week high
$8.92
52 Week high$8.92
52 Week low
$1.90
52 Week low$1.90
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.